Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists discover the basis of allergic reactions

05.06.2014

The reason why many people are allergic to birch pollen has not been fully clarified yet. It is known that a specific birch pollen protein causes the immune system to overreact.

What makes it an allergen has now been discovered by scientists at the Vetmeduni Vienna. The pollen protein can bind iron. Without iron load the protein becomes an allergen. Environmental factors are possibly the reason for low iron loads in plants. This could explain the increasing numbers of allergies. The research data were published in the Journal of Biological Chemistry.


Birch blossoms release their pollen with the molecule Bet v 1 (turquoise). Bet v 1 loaded with an iron-containing ligand (yellow with gray ball) does not act as an allergen. (Photo: Fotolia.com © lochstampfer, modified by Prof. Luis F. Pacios, Madrid)

Allergies in humans and animals are on the increase. An allergic reaction may cause unpleasant symptoms like hay fever, food intolerance or skin rashes. Allergic reactions may also cause acute and life-threatening symptoms, such as asthma or anaphylactic shock.

A single pollen protein is responsible for allergies

One of the most well known allergens, i.e. substances that cause allergies, is so-called “Bet v 1” from birch pollen (Betula verrucosa). The protein was first produced artificially in the laboratory 25 years ago in Vienna, and is being used as an allergen model for research throughout the world. “Bet v 1” is the principal allergen among hundreds of other proteins of birch pollen. It renders the immune system hypersensitive and leads to the formation of disease-causing antibodies known as IgE immunoglobulins in 95 percent of persons with a pollen allergy.

Birch pollen protein in its iron-loaded state is not allergenic

Until recently it was not known why harmless molecules trigger allergies at all. Scientist Franziska Roth-Walter and her colleagues from the Messerli Research Institute have now found the possible cause. The birch pollen protein “Bet v 1” is very similar to the human protein Lipocalin 2 in terms of structure; Lipocalin 2 is mainly present in the lung. Lipocalin 2 and “Bet v 1” possess so-called molecular pockets with which they can bind iron.

When these pockets remain empty, the birch pollen protein becomes an allergen and is liable to cause allergic reactions in humans and animals. The protein manipulates so-called T-helper 2 cells (Th2 cells), a certain type of immune cells, towards allergy. The human protein Lipocalin 2 also performs tasks of the immune system, depending on its iron loading.

Origin of allergy investigated in the model of birch pollen

In allergic people and other mammals, Th2 cells are predominant compared to Th1 cells. Th2 cells play an important role in allergic reactions and in combating parasites. Th1 cells serve to defend the body against bacterial and viral infections. "A typical feature of allergies is the disruption of the balance between the Th1 and Th2 immune response," explains Professor Erika Jensen-Jarolim, head of the Department of Comparative Medicine at the Messerli Research Institute.

"Investigations currently in progress indicate that we can directly transfer the principle of birch pollen allergens to other allergens with a similar molecular structure. We are thus starting to understand - for the first time - why allergies to pollen, foodstuffs and fungal spores actually arise in the first place."

Environmental factors determine the iron loading of the pollen protein

Scientists at the Messerli Research Institute, a combined facility of the Vetmeduni Vienna, the Meduni Vienna an der University of Vienna, are currently investigating the mechanisms that may contribute to reduced iron loading of “Bet v 1” in plants. "Iron loading of the birch protein may be connected to the aggravated environmental conditions acting on plants," says Jensen-Jarolim.

"In fact, there may be a direct connection between environmental pollution and rising allergy statistics. The most important conclusion from our work is that, in the future, it would make sense to specifically load allergenic molecules of the “Bet v 1” type with iron when they are used as allergy-specific immunotherapy in allergic patients. By doing so, this treatment - which currently takes two to four years - can be greatly shortened and its efficiency can thus be enhanced."

The article „ Bet v 1 from Birch Pollen is a Lipocalin-like Protein acting as Allergen only when devoid of Iron by promoting Th2 lymphocytes“, by Franziska Roth-Walter, Cristina Gomez-Casado, Luis F. Pacios, Nadine Mothes-Lucksch, Georg A. Roth, Josef Singer, Araceli Diaz-Perales and Erika Jensen-Jarolim was published in the Journal of Biological Chemistry. doi: 10.1074/jbc.M114.567875
http://www.jbc.org/content/early/2014/05/07/jbc.M114.567875.long

About the University of Veterinary Medicine, Vienna
The University of Veterinary Medicine, Vienna in Austria is one of the leading academic and research institutions in the field of Veterinary Sciences in Europe. About 1,200 employees and 2,300 students work on the campus in the north of Vienna which also houses five university clinics and various research sites. Outside of Vienna the university operates Teaching and Research Farms. http://www.vetmeduni.ac.at

Scientific Contact:
Prof. Erika Jensen-Jarolim
Messerli Research Institute – Comparative Medicine
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 20577-2660
M +43 664 60257-6260
erika.jensen-jarolim@vetmeduni.ac.at

Scientific Contact:
Dr. Franziska Roth-Walter
Messerli Research Institute – Comparative Medicine
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
M +43 664 60257 6261
franziska.roth-walter@vetmeduni.ac.at

Released by:
Susanna Kautschitsch
Science Communication / Public Relations
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-1153
susanna.kautschitsch@vetmeduni.ac.at

Weitere Informationen:

http://www.vetmeduni.ac.at/en/infoservice/presseinformation/press-releases-2014/...

Dr. Susanna Kautschitsch | idw - Informationsdienst Wissenschaft

Further reports about: Environmental Iron Medicine Veterinary Vetmeduni allergens allergies structure symptoms

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Research reveals how order first appears in liquid crystals

23.05.2018 | Life Sciences

Space-like gravity weakens biochemical signals in muscle formation

23.05.2018 | Life Sciences

NIST puts the optical microscope under the microscope to achieve atomic accuracy

23.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>